Triple-negative breast cancer (TNBC) comprises a subgroup of breast cancers (BC) identified by a lack of expression of the estrogen receptor (ER) and progesterone receptors (PR), and without amplification of Human Epidermal Growth Factor Receptor-2 (HER2 or ERBB2). This evidence concerns the gene PGR and breast carcinoma.